In colon cancer, enhanced SOX2 expression reversed the downregulation of CD133 and CD44 and the upregulation of E-cadherin 58, and inhibition of SOX2 decreased Snail expression, leading to a decrease in the invasive migratory capacity of cells 56. This evidence concerns the gene SOX2 and malignant colon neoplasm.